ETOPOSIDE PHARMACOKINETICS IN PATIENTS WITH NORMAL AND ABNORMAL ORGAN FUNCTION

被引：87

作者：

ARBUCK, SG

DOUGLASS, HO

CROM, WR

GOODWIN, P

SILK, Y

COOPER, C

EVANS, WE

机构：

[1] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT CLIN PHARMACOL & THERAPEUT,BUFFALO,NY 14263

[2] ST JUDE CHILDRENS RES HOSP,DIV PHARMACEUT,MEMPHIS,TN 38101

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1986年 / 4卷 / 11期

关键词：

D O I：

10.1200/JCO.1986.4.11.1690

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1690 / 1695

页数：6

共 16 条

[1]

BOX GEP, 1959, BIOMETRIKA, V46, P77, DOI 10.1093/biomet/46.1-2.77

[2] STUDIES OF CROSS-RESISTANCE, SYNERGISTIC COMBINATIONS AND BLOCKING OF ACTIVITY OF PLATINUM DERIVATIVES [J].

BURCHENAL, JH ;

KALAHER, K ;

DEW, K ;

LOKYS, L ;

GALE, G .

BIOCHIMIE, 1978, 60 (09) :961-965

[3]

COLOMBO T, 1983, P AM ASSOC CANC RES, V24, P292

[4]

CREAVEN PJ, 1982, CANCER CHEMOTH PHARM, V7, P133

[5]

DINCALCI M, 1982, CANCER CHEMOTH PHARM, V7, P141

[6]

DINCALCI M, 1982, P AM ASSOC CANC RES, V23, P131

[7]

EVANS WE, 1982, CANCER CHEMOTH PHARM, V7, P147

[8]

HANDE KR, 1984, CANCER RES, V44, P379

[9]

HO DHW, 1983, P AM ASSOC CANC RES, V24, P131

[10]

METZLER CM, 1974, BIOMETRICS, V30, P562

← 1 2 →